(Q45292917)

11 December 2017

title

Getting a handle on Huntington's disease: silencing neurodegeneration (English)

1 reference

11 December 2017

0 references

1 reference

Albert R La Spada

1 reference

11 December 2017

language of work or name

English

0 references

publication date

1 March 2009

1 reference

11 December 2017

1 reference

11 December 2017

1 reference

11 December 2017

1 reference

11 December 2017

page(s)

252-253

1 reference

Artificial miRNAs mitigate shRNA-mediated toxicity in the brain: implications for the therapeutic development of RNAi

11 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNM0309-252

Polyglutamine diseases: emerging concepts in pathogenesis and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0309-252

Toxic proteins in neurodegenerative disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0309-252

Reversal of neuropathology and motor dysfunction in a conditional model of Huntington's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0309-252

Recovery from polyglutamine-induced neurodegeneration in conditional SCA1 transgenic mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0309-252

RNAi suppresses polyglutamine-induced neurodegeneration in a model of spinocerebellar ataxia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0309-252

Normal huntingtin function: an alternative approach to Huntington's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0309-252

Polyglutamines placed into context

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0309-252

Silencing polyglutamine degeneration with RNAi

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0309-252

Progress in antisense technology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0309-252

Antisense oligonucleotide therapy for neurodegenerative disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0309-252

From Charcot to Lou Gehrig: deciphering selective motor neuron death in ALS

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0309-252

Genomic rearrangements and gene copy-number alterations as a cause of nervous system disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0309-252

21 January 2018

Identifiers

DOI

10.1038/NM0309-252

1 reference

Dimensions Publication ID

11 December 2017

1013827870

0 references

1 reference